Skip to main content
. 2012 Oct 4;29(12):1397–1404. doi: 10.1007/s10815-012-9864-1

Table 1.

Outcomes of oocyte quality and embryo development across the FF L:A ratio tertiles

Embryological outcomes Low FF L:A Med FF L:A High FF L:A All P
Age (years) 37.6 ± 5.1 35.6 ± 4.0 36.4 ± 3.2 36.6 ± 4.2 0.555
BMI (kg/m2) 20.4 (4.4) 23.4 (2.5) 27.3 (13.3) 23.4 (4.3) 0.036
Baseline serum AMH (ng/mL) 2.4 (2.6) 1.2 (1.2) 2.3 (1.9) 1.6 (2.0) 0.530
Peak serum estradiol (pg/mL) 2384 ± 1033 1717 ± 792 2259 ± 1530 2114 ± 1113 0.339
Oocytes studied N 24 25 25 74
Mature (MII) oocytes N (% total) 22 (91.7) 23 (92.0) 23 (92.0) 68 0.796
Normal fertilization (2PN) N (% MII) 13 (59.1) 16 (69.6) 18 (78.3) 47 0.223
Successful cleavage N (% 2PN) 6 (46.2) 11 (68.8) 15 (83.3) 32 0.050
Viable cleavage morphology N (% 2PN) 8 (38.5) 10 (62.5) 15 (83.3) 30 0.019
Successful blastulation N (% 2PN) 0 2 (33.3) 11 (78.6) 13a 0.028a
Viable blastocyst morphology N (% 2PN) 0 2 (33.3) 2 (14.3) 4a 0.574a

AMH = anti-mullerian hormone; FF = follicular fluid; the L:A ratio = leptin to adiponectin ratio; Med = medium; MII = meiosis II; 2PN = 2 pronuclei. Values are reported as mean ± standard deviation for age and peak serum estradiol, as median (interquartile range) for body mass index and baseline serum AMH, and as number and percent for all other rows. P values were calculated using the One-Way Anova for age and peak serum estradiol, the nonparametric median test for body mass index and baseline serum AMH, the extended Mantel-Haenszel Chi Square test for linear trend for oocyte and embryo outcomes. The FF L:A tertiles are separated by 3.71E−3 and 19.79E−3

aFrom 13 blastocyst-only cycles (37 total oocytes and 23 normally fertilized oocytes)